New Nordic Healthbrands AB (SE:NNH)

:NNH

NNH

New Nordic Healthbrands AB

RESEARCH TOOLSreports

Want to see SE:NNH full AI Analyst Report?

New Nordic Healthbrands AB (NNH) Price & Analysis

0 Followers

NNH Stock Chart & Stats

kr21.50

kr0.00(0.00%)

At close: Mar 05 4:00 PM EST

kr21.50

kr0.00(0.00%)

Day’s Range― - ―

52-Week Rangekr15.00 - kr28.00

Previous CloseN/A

Volume5.00K

Average Volume (3M)5.45K

Market Cap

kr99.74M

Enterprise Valuekr115.94M

Total Cash (Recent Filing)kr16.55M

Total Debt (Recent Filing)kr35.84M

Price to Earnings (P/E)17.5

Beta0.24

Next Earnings

Aug 05, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding6,195,200

10 Day Avg. Volume3,153

30 Day Avg. Volume5,451

Financial Highlights & Ratios

PEG Ratio-0.08

Price to Book (P/B)1.39

Price to Sales (P/S)0.25

P/FCF Ratio18.98

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue GrowthRevenue grew 16.9% in 2025, demonstrating the company can expand sales and regain demand momentum. Sustained top-line growth supports scale economics, distribution leverage and the capacity to invest in brands or channels, underpinning durable operating stability if margins normalize.

Balance Sheet HealthDebt-to-equity improving to ~0.35 and fairly stable equity give the company manageable leverage and financial flexibility. With lower relative debt and an improving capital structure, NNH has more capacity to fund targeted investments or absorb shocks without over-relying on external financing.

Return To ProfitabilityAfter several loss-making years, NNH returned to modest profitability in 2025 with ROE ~7.9% and net margin ~1.4%. A credible profit recovery increases potential for internally funded growth and signals operational remediation; sustained profits would materially strengthen long-term cash generation.

Bears Say

Volatile Cash GenerationOperating and free cash flow have been swingy—negative in multiple years and only episodically strong—undermining the reliability of internal funding. This variability hampers steady reinvestment, complicates capital allocation and increases reliance on external financing during downturns.

Gross Margin PressureAn unusually low 2025 gross margin relative to prior years points to either sustained input-cost pressure or adverse product mix shifts. If structural, compressed gross margins will limit operating leverage, erode profitability even as top line grows, and challenge the durability of recent earnings improvements.

Inconsistent Profitability HistoryMultiyear losses followed by a small 2025 profit indicate uneven operational performance and execution risk. Such stop-start profitability reduces stakeholder confidence, complicates long-term planning, and means management must sustain improvement to de-risk the business model and solidify cash generation.

NNH FAQ

What was New Nordic Healthbrands AB’s price range in the past 12 months?

New Nordic Healthbrands AB lowest stock price was kr15.00 and its highest was kr28.00 in the past 12 months.

What is New Nordic Healthbrands AB’s market cap?

New Nordic Healthbrands AB’s market cap is kr99.74M.

When is New Nordic Healthbrands AB’s upcoming earnings report date?

New Nordic Healthbrands AB’s upcoming earnings report date is Aug 05, 2026 which is in 96 days.

How were New Nordic Healthbrands AB’s earnings last quarter?

Currently, no data Available

Is New Nordic Healthbrands AB overvalued?

According to Wall Street analysts New Nordic Healthbrands AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does New Nordic Healthbrands AB pay dividends?

New Nordic Healthbrands AB pays a Annually dividend of kr1.25 which represents an annual dividend yield of N/A. See more information on New Nordic Healthbrands AB dividends here

What is New Nordic Healthbrands AB’s EPS estimate?

New Nordic Healthbrands AB’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does New Nordic Healthbrands AB have?

New Nordic Healthbrands AB has 6,195,200 shares outstanding.

What happened to New Nordic Healthbrands AB’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of New Nordic Healthbrands AB?

Currently, no hedge funds are holding shares in SE:NNH

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

New Nordic Healthbrands AB

New Nordic Healthbrands AB (publ) develops and markets dietary supplements, natural medicines, and cosmetic products in Sweden. The company provides vitality products for immune system. The company provides balm, repair mask, shampoo, shine serum, chewing gum, face and eye cream, and dietary supplements. It offers its products under Hair Volume, Skin Care, Beauty In & Out, and New Nordic brand names. The company sells its products through pharmacies, department stores, health stores, travel retailers, and beauty shops, as well as through online stores in 41 countries in North America, Canada, Europe, the United States, and internationally. New Nordic Healthbrands AB (publ) was founded in 1990 and is headquartered in Malmö, Sweden.